Harvest Autologous Hemobiologics

Harvest Technologies, operating as Harvest Autologous Hemobiologics, is a leader in the development of point-of-care autologous cell therapy systems. The company's core technology, the SmartPReP platform, enables clinicians to rapidly process a patient's own blood or bone marrow to produce concentrated biologics such as Platelet-Rich Plasma (PRP) and Bone Marrow Aspirate Concentrate (BMAC). These autologous hemobiologics are rich in growth factors and regenerative cells, which are used to accelerate healing in orthopedics, cardiovascular surgery, and wound management. Following its acquisition by Terumo BCT, the company has expanded its global reach, providing standardized and automated solutions for regenerative medicine in clinical settings. Their products are designed to deliver high cell yields and consistent results within the surgical timeframe.